Maureen E. Haynes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maureen E. Haynes has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- William A. Muller
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
4 shared publications - David P. Sullivan
Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
3 shared publications - Meital Gewirtz
Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Medical Scientist Training Program, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
2 shared publications - Vivienne Fang
Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois; Medical Scientist Training Program, Northwestern University, Feinberg School of Medicine, Chicago, Illinois
2 shared publications - Christine B. Magdongon
Department of Microbiology-Immunology, Northwestern University, Feinberg School of Medicine, Chicago, USA
1 shared publication David P. Sullivan
Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
1 shared publication
Latest Publications
- 2 April 2026
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (10) , 2164-2177
Platelet Endothelial Cell Adhesion Molecule–Dependent Leukocyte Transmigration Is an Essential Early Event in Endotoxin-Induced Uveitis
- 2 April 2026
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (10) , 2164-2177
Platelet Endothelial Cell Adhesion Molecule–Dependent Leukocyte Transmigration Is an Essential Early Event in Endotoxin-Induced Uveitis
- 16 October 2025
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (2) , 359-368
Specialized Pro-Resolving Mediators MaR1 and LXA4 Resolve Inflammation During Acute Chemical Lung Injury in the Absence of Neutrophils
- 16 October 2025
- Published by Elsevier in The American Journal of Pathology
- Vol. 196 (2) , 359-368
Specialized Pro-Resolving Mediators MaR1 and LXA4 Resolve Inflammation During Acute Chemical Lung Injury in the Absence of Neutrophils
- Open Access
KSHV-encoded vIRF3 Cooperates with Cellular IRF4 to Drive Super-Enhancer Activity through Complex DNA Elements
The Kaposi’s sarcoma-associated herpesvirus (KSHV) oncoprotein vIRF3 is essential for the survival of primary effusion lymphoma (PEL) cells. vIRF3 cooperates with cellular IRF4 to activate super-enhancers (SEs) driving oncogenes including MYC and IRF4 itself. However, the vIRF3/IRF4-responsive DNA sequences underlying this cooperation are unknown. Investigating the IRF4-SE, we mapped its vIRF3/IRF4-responsiveness to a complex ∼83 bp region, which retained cooperative activation by vIRF3 and IRF4 and was activated by vIRF3 but not IRF4 alone. vIRF3-mediated activation depended on an AP1 site, while the cooperation of vIRF3 with IRF4 required the DNA binding ability of IRF4 and IRF-related motifs that do not participate in canonical AP1-IRF (AICE) composite sites. These motifs are necessary but insufficient to confer responsiveness outside their native sequence context, suggesting that vIRF3/IRF4-mediated IRF4-SE activation requires an extended composite element. DNA pulldowns confirmed the importance of the identified motifs for association of vIRF3 and IRF4 with the IRF4-SE. A PEL MYC-SE similarly depended on an extended responsive element containing a critical AP1 site, within a functional AICE motif. Together, our results show that vIRF3 activates oncogenic SEs by co-opting complex genetic elements that may accommodate previously unknown IRF4 binding configurations, improving our understanding of vIRF3 and IRF4-dependent oncogenesis. Graphical
Open AccessKSHV-encoded vIRF3 Cooperates with Cellular IRF4 to Drive Super-Enhancer Activity through Complex DNA Elements
The Kaposi’s sarcoma-associated herpesvirus (KSHV) oncoprotein vIRF3 is essential for the survival of primary effusion lymphoma (PEL) cells. vIRF3 cooperates with cellular IRF4 to activate super-enhancers (SEs) driving oncogenes including MYC and IRF4 itself. However, the vIRF3/IRF4-responsive DNA sequences underlying this cooperation are unknown. Investigating the IRF4-SE, we mapped its vIRF3/IRF4-responsiveness to a complex ∼83 bp region, which retained cooperative activation by vIRF3 and IRF4 and was activated by vIRF3 but not IRF4 alone. vIRF3-mediated activation depended on an AP1 site, while the cooperation of vIRF3 with IRF4 required the DNA binding ability of IRF4 and IRF-related motifs that do not participate in canonical AP1-IRF (AICE) composite sites. These motifs are necessary but insufficient to confer responsiveness outside their native sequence context, suggesting that vIRF3/IRF4-mediated IRF4-SE activation requires an extended composite element. DNA pulldowns confirmed the importance of the identified motifs for association of vIRF3 and IRF4 with the IRF4-SE. A PEL MYC-SE similarly depended on an extended responsive element containing a critical AP1 site, within a functional AICE motif. Together, our results show that vIRF3 activates oncogenic SEs by co-opting complex genetic elements that may accommodate previously unknown IRF4 binding configurations, improving our understanding of vIRF3 and IRF4-dependent oncogenesis. Graphical
- 1 July 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 329 (1) , L112-L125
PMN recruitment in inflammatory lung injury models follows classical transendothelial migration paradigms requiring PECAM-1 and CD99
Previous studies have shown that neutrophil extravasation in the lung was selectin-independent and the requirement for leukocyte integrins was stimulus-dependent. This study demonstrates that PECAM-1 and CD99 are required for PMN transmigration during chemical, bacterial, and ischemia/reperfusion lung inflammation. We show directly in real time, using intravital microscopy, that neutrophils extravasate from alveolar capillaries. Blocking antibodies against PECAM-1 or CD99 prevented transmigration into the lung airspace, just as they prevent transmigration in the systemic circulation.
- 1 July 2025
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 329 (1) , L112-L125
PMN recruitment in inflammatory lung injury models follows classical transendothelial migration paradigms requiring PECAM-1 and CD99
Previous studies have shown that neutrophil extravasation in the lung was selectin-independent and the requirement for leukocyte integrins was stimulus-dependent. This study demonstrates that PECAM-1 and CD99 are required for PMN transmigration during chemical, bacterial, and ischemia/reperfusion lung inflammation. We show directly in real time, using intravital microscopy, that neutrophils extravasate from alveolar capillaries. Blocking antibodies against PECAM-1 or CD99 prevented transmigration into the lung airspace, just as they prevent transmigration in the systemic circulation.
- 1 February 2024
- Published by Elsevier in The American Journal of Pathology
- Vol. 194 (5) , 628-636
Neutrophil Infiltration and Function in the Pathogenesis of Inflammatory Airspace Disease
- 1 February 2024
- Published by Elsevier in The American Journal of Pathology
- Vol. 194 (5) , 628-636
Neutrophil Infiltration and Function in the Pathogenesis of Inflammatory Airspace Disease